Ad is loading...
RPMGX
Price
$109.51
Change
-$2.16 (-1.93%)
Updated
Nov 15 closing price
TRMNX
Price
$21.35
Change
-$0.29 (-1.34%)
Updated
Nov 15 closing price
Ad is loading...

RPMGX vs TRMNX

Header iconRPMGX vs TRMNX Comparison
Open Charts RPMGX vs TRMNXBanner chart's image
T. Rowe Price Mid-Cap Growth
Price$109.51
Change-$2.16 (-1.93%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Index
Price$21.35
Change-$0.29 (-1.34%)
VolumeN/A
CapitalizationN/A
RPMGX vs TRMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RPMGX vs. TRMNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMGX is a StrongSell and TRMNX is a Buy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31B vs. TRMNX (231M). TRMNX pays higher dividends than RPMGX: TRMNX (0.70) vs RPMGX (0.05). RPMGX was incepted earlier than TRMNX: RPMGX (32 years) vs TRMNX (9 years). TRMNX is a more actively managed with annual turnover of: 29.50 vs. RPMGX (21.70). RPMGX (2500) and TRMNX (2500) have matching initial minimum investment requirements. TRMNX annual gain was more profitable for investors over the last year : 36.90 vs. RPMGX (14.13). TRMNX return over 5 years is better than : 60.54 vs. RPMGX (13.50).
RPMGXTRMNXRPMGX / TRMNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years9 years-
Gain YTD9.46620.96345%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets31B231M13,420%
Annual Yield % from dividends0.050.708%
Returns for 1 year14.1336.9038%
Returns for 3 years-18.72-0.662,820%
Returns for 5 years13.5060.5422%
Returns for 10 years35.50N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRB60.080.94
+1.59%
H&R Block
DE398.954.31
+1.09%
Deere & Company
GNE15.790.02
+0.13%
GENIE ENERGY Ltd
CMRE14.39-0.16
-1.10%
Costamare
SPRO1.18-0.07
-5.60%
Spero Therapeutics